You are here:

Astellas Pharma Ltd

Name SMC ID No Status Sub. Type
 
capsaicin (Qutenza) 673/11 Restricted Resubmission
capsaicin (Qutenza) 1140/16 Not Recommended Non submission
capsaicin cutaneous patch (Qutenza) 673/11 Restricted Full submission
enzalutamide (Xtandi) 1066/15 Accepted IRP
enzalutamide (Xtandi) 1066/15 Not Recommended Full submission
enzalutamide (Xtandi) 911/13 Accepted Full submission
fidaxomicin (Dificlir) 791/12 Restricted Full submission
micafungin (Mycamine) 497/08 Restricted Full submission
mirabegron (Betmiga) 862/13 Accepted Full submission
solifenacin and tamsulosin (Vesomni) 945/14 Accepted Abbreviated Submission
tacrolimus (Protopic) 608/10 Accepted Full submission
tacrolimus (Protopic) 0.1% ointment 609/10 Accepted Full submission
tacrolimus 0.5mg, 1mg, 5mg prolonged release capsule (Advagraf) 402/07 Accepted Abbreviated Submission
tacrolimus granules for suspension (Modigraf) 657/10 Restricted Abbreviated Submission
tacrolimus, 5mg/ml concentrate for infusion and 0.5mg, 1mg, 5mg hard capsules (Prograf) 346/07 Restricted Full submission

Back